Surveillance for AIDS in a central African city. Kinshasa, Zaire. 1986

J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot

Surveillance for acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire, was initiated in July 1984, using a modified version of the case definition developed by the Centers for Disease Control. During the first eight months, 332 patients met all clinical and laboratory criteria; surveillance information was available for 295 (89%) of these patients. Of the sera tested from these patients, 99% had antibodies to human T-cell lymphotropic virus type III/lymphadenopathy-associated virus by both enzyme-linked immunosorbent assay and Western blot procedures. The male-female case ratio was 1:1.1; the mean age of patients was 33.6 years (median, 32 years; range, 1.5 to 64 years); and men were significantly older than women (mean, 37.4 vs 30.0 years). The estimated incidence rate for adults in Kinshasa is 380 cases per 1 million people per year. Peak age-specific incidence rates for men and women occurred among the 30- to 39-year age group, although the rate for men in this age group was 24% higher than the rate for women (786 vs 601 per 1 million). A reasonable estimate of the current annual incidence of AIDS is 550 to 1,000 cases per 1 million people. Surveillance of AIDS in Zaire provides important information on transmission patterns and rates in Africa.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011159 Population Surveillance Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy. Surveillance, Population
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
January 1991, AIDS (London, England),
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
December 1993, Social science & medicine (1982),
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
January 1991, Antibiotics and chemotherapy,
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
December 1987, Annales de la Societe belge de medecine tropicale,
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
January 1985, Annales de la Societe belge de medecine tropicale,
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
January 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene,
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
October 1991, Presse medicale (Paris, France : 1983),
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
January 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene,
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
January 1989, Bulletin of the World Health Organization,
J M Mann, and H Francis, and T Quinn, and P K Asila, and N Bosenge, and N Nzilambi, and K Bila, and M Tamfum, and K Ruti, and P Piot
June 1995, Annales de la Societe belge de medecine tropicale,
Copied contents to your clipboard!